Navigation Links
Autism Science Foundation Launches Operations; New Advocacy Group Will Focus on Non-vaccine-related Autism Research
Date:4/18/2009

The Autism Science Foundation, a new nonprofit organization dedicated to supporting and funding autism research, launched its operations today, debuting its web site (www.autismsciencefoundation.org) and kicking off its "First 100 Days" fundraising drive. ASF's mission is to support autism research by providing funding and other assistance to scientists and organizations conducting, facilitating, publicizing and disseminating autism research. The organization is co-founded by Alison Singer, formerly Executive Vice President of Autism Speaks, and Karen London, co-founder of the National Alliance for Autism Research (NAAR). The Autism Science Foundation will focus on non-vaccine-related autism research.

Seattle, WA (PRWEB) April 18, 2009 -- The Autism Science Foundation, a new not-for-profit organization dedicated to supporting and funding autism research, launched its operations today, debuting its web site (www.autismsciencefoundation.org) and kicking off its "First 100 Days" fundraising drive with an announcement at the Association of Healthcare Journalists' Annual Conference. The organization is co-founded by Alison Singer, formerly Executive Vice President of Autism Speaks, and Karen London, co-founder of the National Alliance for Autism Research (NAAR). Both Singer and London are parents of children with autism. Singer will serve as President of the new organization.

Singer resigned from Autism Speaks in January of this year, citing disagreement with the group's decision to continue to fund more vaccine research despite multiple scientific studies exonerating vaccines as a cause of autism. "After I left Autism Speaks, I heard over and over from parents who said they needed an organization they could trust to fund nothing but the very best science; science that would open new doors and ask questions that have not yet been answered. That's what we'll do at the Autism Science Foundation."

ASF's mission is to support autism research by providing funding and other assistance to scientists and organizations conducting, facilitating, publicizing and disseminating autism research. The organization will also provide information about autism to the general public and will serve to increase awareness of autism spectrum disorders and the needs of individuals and families affected by autism.

"This organization will adhere to the rigorous scientific standards and values that defined NAAR during its 12 year, pre-merger history," said London. "Outstanding research is the greatest gift we can offer our families. Every research dollar needs to count." Founded in 1994, NAAR was the first nonprofit organization in the world dedicated to advancing autism research. In 2006, NAAR merged with Autism Speaks.

The Autism Science Foundation's mission is premised on the following facts and principles:

  • Autism is known to have a strong genetic component. Research must aim to discover the mechanisms of action that trigger autism, as well as safe, effective and novel treatments to enhance the quality of life for children and adults currently affected.
  • Early diagnosis and early intervention are critical to helping people with autism reach their potential, but educational, vocational and support services must be applied across the lifespan. Science has a critical role to play in creating evidence-based, effective lifespan interventions.
  • Vaccines save lives; they do not cause autism. Numerous studies have failed to show a causal link between vaccines and autism. Vaccine safety research should continue to be conducted by the public health system in order to ensure vaccine safety and maintain confidence in our national vaccine program, but further investment of limited autism research dollars is not warranted at this time.

"We know more about autism than we did just a few years ago. For example, new discoveries in neuroscience, genetics, and epigenetics offer hope for improving the lives of people with autism," said Dr. Edwin Trevathan, Director of CDC's National Center on Birth Defects and Developmental Disabilities. "It is important that we apply these scientific advances to public health research to learn what causes autism spectrum disorders, how to treat autism, and eventually how to prevent autism-associated disability. As we all strive to follow where the science leads, the Autism Science Foundation will play an important role."

"We need the most rigorous science to understand autism and develop new treatments," said Dr. Tom Insel, Director of the National Institute of Mental Health and Chair of the federal Interagency Autism Coordinating Committee (IACC). "I look forward to the Autism Science Foundation joining the public-private partnership described in the new strategic plan for autism research."

"As we attempt to understand the causes of autism, and to develop optimal treatment programs, it is critical that parents have access to information that is based upon the best medical evidence," said David T. Tayloe Jr., MD, FAAP, President of the American Academy of Pediatrics, an organization of more than 60,000 pediatricians dedicated to the health, safety and well being of infants, children, adolescents and young adults. "We welcome the chance to work closely with the Autism Science Foundation to improve the lives of children diagnosed with autism."

Joining London and Singer on the Autism Science Foundation Board of Directors are Dr. Paul Offit, Chief of Infectious Diseases at Children's Hospital of Philadelphia and author of the critically acclaimed Autism's False Prophets; Bad Science, Risky Medicine and the Search for a Cure, and Michael Lewis, attorney, mediator and grandfather of a child with autism. ASF's Scientific Advisory Board, still in formation, includes Dr. Emanuel DiCicco-Bloom (UMDNJ-Robert Wood Johnson Medical School; past program chair of the International Society for Autism Research); Dr. Ami Klin (Yale Child Study Center); Dr. Harold Koplewicz (NYU Child Study Center); Dr. Sharon Humiston (University of Rochester); Dr. Eric London (NYS Institute for Basic Research in Developmental Disabilities and co-founder of NAAR); Dr. Catherine Lord (University of Michigan); and Dr. Matthew State (Yale Medical School).

To learn more about the Autism Science Foundation or to make a donation, visit www.autismsciencefoundation.org

###

Read the full story at http://www.prweb.com/releases/2009/04/prweb2333904.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Melatonin is an effective treatment for sleep problems in children with autism
2. April is National Autism Awareness Month: LoJack Hosts Educational Podcast Featuring Panel of Experts Addressing Autism Issues
3. The Help Group Launches Multifaceted Autism Awareness Campaign
4. Metro Parents Second Annual Living With Autism Workshop Features Local Experts Who Are Intimately Involved in Improving the Lives of These Special Children
5. Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism
6. Songs Give Back for Autism Awareness Month
7. Uncovering the Secrets of Getting California Health Insurance to Pay for Autism Treatments
8. Ask.com Supports Autism Speaks with Innovative Donation Program
9. Kyles Treehouse Launches Autism151.com for Autism Awareness Month
10. Autism Software Developer Announces Hiring of Susan DuRant as Director of Education
11. Autism Society of America Joins MedicAlert Foundation to offer MedicAlert(R) + Safe and Sound(R) - 24-Hour Comprehensive Protection System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... , ... ChenMed , a leading provider of value-based care for seniors, ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family Medicine ... Ambulatory Services for the UVA Health System, brings 30 years of highly relevant experience ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... a telemedicine platform, in which their iMedSecure™ comes included with each system installation. ... encrypted live images to remote participants for real-time collaboration and immediate decision-making requirements. ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... FDAnews Webinar**, Aug. 9, 2017 — 1:30 p.m. – 3:00 p.m. ET, ... inspections and boosting quality. , It’s known as the “CY2016 Annual FDA Medical ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... protection services since 2014, top travel insurance solution company VisitorsCoverage Inc. has launched ... sell all major international travel insurance products online, under their own brand. The ...
(Date:7/20/2017)... ... 19, 2017 , ... At Creekwood Dental Arts, Drs. Donna G. Miller and ... dental implants in Waco, TX, using the latest dental technology for digital ... they can capture details in the oral cavity for accurate diagnoses and customized care ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... MINNEAPOLIS , July 5, 2017 Pace Analytical, a company of ... announcing today that they have acquired ESC Lab Sciences, further solidifying their position ... the United States . ... Steve Vanderboom- President and CEO of Pace Analytical ... of ESC Lab Sciences out of Mt Juliet, TN , ...
(Date:6/30/2017)... , June 30, 2017  AVACEN Medical (AVACEN) announced the ... The research describes the use of its AVACEN Treatment Method ... suffering from fibromyalgia. ... AVACEN Medical ... characterized by chronic widespread pain. It affects approximately 200 to 400 million ...
(Date:6/20/2017)... HILLS, Calif. , June 20, 2017 SkylineDx ... the use of MMprofiler with SKY92, the company,s prognostic ... In a poster presentation at the 22 nd ... Madrid, Spain , SkylineDx researchers will demonstrate ... patients. In a separate e-poster presentation ...
Breaking Medicine Technology: